| |
C-Type Natriuretic Peptide (CNP) (1-22), human  |
|
|

| Cat. No. |
Size |
Price |
Figures |
RP11110-0.5 mg
| 0.5 mg | $ 85.50 | MSDS: 20080814045355 (PDF)
References:
- Anderson WG, et al. The effects of freshwater to seawater transfer on circulating levels of angiotensin II, C-type natriuretic peptide and arginine vasotocin in the euryhaline elasmobranch, Carcharhinus leucas. Gen. Comp. Endocrinol. May 2006; 147(1): 39-46.
- Yeh LC, et al. C-type natriuretic peptide enhances osteogenic protein-1-induced osteoblastic cell differentiation via Smad5 phosphorylation. J. Cell. Biochem. Feb 2006; 97(3): 494-500.
- Hong TC, et al. Brain natriuretic peptide and C-type natriuretic peptide are differently regulated by age but similarly elevated in coronary artery disease. Acta. Cardiol. Feb 2006; 61(1): 1-5.
|
|---|
| Full Name | | C-Type Natriuretic Peptide (CNP) (1-22), human |
|
| Alias |
CNP |
Sequence (one-letter code) |
GLSKGCFGLKLDRIGSMSGLGC | Sequence (three-letter code) | {GLY}{LEU}{SER}{LYS}{GLY}{CYS}{PHE}{GLY}{LEU}{LYS} {LEU}{ASP}{ARG}{ILE}{GLY}{SER}{MET}{SER}{GLY}{LEU} {GLY}{CYS} | | Chemical Bridge | Disulfide bridge: Cys6-Cys22 |
|---|
| Description | C-type natriuretic peptide is produced in the hypothalamus, anterior pituitary, and most major endocrine glands. C-type natriuretic peptide has potent venodilatory and coronary vasodilatory effects, but minimal effects on renal function. |
|---|
| Solubility | Soluble in water. The contents of this vial have been accurately determined. Both the stopper and the vial have been siliconized. Do not attempt to weight out a smaller portion of the contents. |
|---|
| Formula | C93H157N27O28S3 | | M.W. | 2197.6 | | Cas | 127869-51-6 |
|---|
| Purity | > 95% | | Storage | Store at -20°C. | | Notes | Pharmacological spectrum similar to ANP and BNP. |
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|